Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of istradefylline versus entacapone versus placebo in Parkinson's disease with motor response complications on levodopa
2004-000817-20Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease (PD) comparing Istradefylline + levodopa, Entacapone + levodopa and Placebo + levodopa (3 arms). Primary endpoint: Change from baseline in percentage of awake time per day spent in the OFF state at endpoint. Started Oct 2004; status: completed.
02
Drugs
Istradefyllineentacapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2004-000817-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000817-20.